Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JSPR Jasper Therapeutics

Market Closed 08-28 16:00:00 EDT

0.6997

+0.0005

+0.07%

盘后0.7300

+0.0303+4.33%

19:36 EDT

High0.7095	Low0.6601	Vol267.42K
Open0.7095	D1 Closing0.6992	Amplitude7.07%
Mkt Cap23.28M	Tradable Cap20.99M	Total Shares33.27M
T/O182.02K	T/O Rate0.89%	Tradable Shares30.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JSPR","market":"US","secType":"STK","nameCN":"Jasper Therapeutics","latestPrice":0.6997,"timestamp":1787947200000,"preClose":0.6992,"halted":0,"volume":267423,"hourTrading":{"tag":"盘后","latestPrice":0.73,"preClose":0.6997,"latestTime":"19:36 EDT","volume":2619,"amount":1908.13789,"timestamp":1787960186352,"change":0.0303,"changeRate":0.043304,"amplitude":0.084593},"delay":0,"changeRate":0.0007151029748282964,"floatShares":29996700,"shares":33274600,"eps":-0.93,"marketStatus":"Market Closed","change":0.0005,"latestTime":"08-28 16:00:00 EDT","open":0.7095,"high":0.7095,"low":0.6601,"amount":182016.8117898,"amplitude":0.070652,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.93,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.6992,"preHourTrading":{"tag":"盘前","latestPrice":0.6981,"preClose":0.6992,"latestTime":"08:04 EDT","volume":121,"amount":84.37709577,"timestamp":1787918676187,"change":-0.0011,"changeRate":-0.001573,"amplitude":0.004434},"postHourTrading":{"tag":"盘后","latestPrice":0.73,"preClose":0.6997,"latestTime":"19:36 EDT","volume":2619,"amount":1908.13789,"timestamp":1787960186352,"change":0.0303,"changeRate":0.043304,"amplitude":0.084593},"volumeRatio":0.7004782960196639,"impliedVol":0.7235,"impliedVolPercentile":0.239},"requestUrl":"/m/hq/s/JSPR","defaultTab":"news","newsList":[{"id":"2662820960","title":"Jasper Therapeutics Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820960","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820960?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:31","pubTimestamp":1787607101,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics announces special shareholder meetingJasper Therapeutics will hold a virtual special shareholder meeting on Sept. 30, 2026.Vote on a reverse stock split within a 1-for-15 to 1-for-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL7r4H4t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468576","title":"Analysts Offer Insights on Healthcare Companies: Aptevo Therapeutics (APVO) and Jasper Therapeutics (JSPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468576?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:10","pubTimestamp":1787040626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aptevo Therapeutics (APVO) and Jasper Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aptevo-therapeutics-apvo-and-jasper-therapeutics-jspr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aptevo-therapeutics-apvo-and-jasper-therapeutics-jspr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","XLV","APVO","BK4139","XBI","LU0029874061.USD","LABU","JSPR","BK4588","BK4585","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660846164","title":"Jasper Therapeutics initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660846164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660846164?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:02","pubTimestamp":1786964528,"startTime":"0","endTime":"0","summary":"Piper Sandler initiated coverage of Jasper Therapeutics (JSPR) with an Overweight rating and $2 price target The company’s lead asset KP-104 simult...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-initiated-with-an-overweight-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-initiated-with-an-overweight-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659954178","title":"Novo, LightPath, Jasper, UMAC, CCEP Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2659954178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659954178?lang=en_us&edition=fundamental","pubTime":"2026-08-15 17:01","pubTimestamp":1786784479,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($NVO) ), ( ($LPTH) ), ( ($JSPR) ), ( ($UMAC) ) and ( ($CCEP) ). Here is a breakdown of their recent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/novo-lightpath-jasper-umac-ccep-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/novo-lightpath-jasper-umac-ccep-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0550127509.SGD","SG9999003800.SGD","LU1093756168.USD","LU2360108059.USD","BK4177","THNR","BK4603","BK4007","BK4532","LU0997587240.USD","BK4139","NVOX","NVO","LU0997586606.USD","LU2298321311.HKD","DRNZ","NVOH","LU2237957902.USD","LPTH","OZEM","SG9999011175.SGD","JSPR","LU2041044095.USD","LU0154236417.USD","LU2092937221.SGD","UMAC","BK4157","LU0048578792.EUR","LU1119994140.HKD","CCEP","PPH","LU1093756325.SGD","BK4599","LU2237957811.SGD","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659177129","title":"Jasper Therapeutics Q2 EPS $(0.10) Beats $(0.26) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659177129","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659177129?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:27","pubTimestamp":1786739228,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.26) by 61.54 percent. This is a 94.25 percent increase over losses of $(1.74) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61228671/jasper-therapeutics-q2-eps-0-10-beats-0-26-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Jasper Therapeutics Q2 EPS $(0.10) Beats $(0.26) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123852","title":"Jasper Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123852","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123852?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:20","pubTimestamp":1786724409,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryJasper Therapeutics, Inc.JSPR.OQreported a quarterly adjusted loss of 10 cents per share for the quarter ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B19C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140242","title":"Jasper Therapeutics Q2 Loss Per Share Beats Estimates, Raises $132 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140242","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140242?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:12","pubTimestamp":1786720324,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mlnOverviewUS biotech firm's fiscal Q2 net loss per share was $0.10, beating analyst expectationsCompany completed acquisition of Kir","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0L2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","JSPR","ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121140","title":"Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121140?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:00","pubTimestamp":1786719600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA5CM4WQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140123","title":"Jasper Therapeutics Q2 Net Income USD -2.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140123?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:00","pubTimestamp":1786719600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLX1J47B1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658752789","title":"Biren Amin Initiates Buy on Jasper Therapeutics, Highlighting KP-104’s Differentiated Dual-Pathway Mechanism and $1.5B Peak Sales Potential in Kidney Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2658752789","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658752789?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:45","pubTimestamp":1786527932,"startTime":"0","endTime":"0","summary":"Biren Amin, an analyst from Piper Sandler, has initiated a new Buy rating on Jasper Therapeutics (JSPR). Biren Amin has given his Buy rating due to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/biren-amin-initiates-buy-on-jasper-therapeutics-highlighting-kp-104s-differentiated-dual-pathway-mechanism-and-1-5b-peak-sales-potential-in-kidney-diseases-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/biren-amin-initiates-buy-on-jasper-therapeutics-highlighting-kp-104s-differentiated-dual-pathway-mechanism-and-1-5b-peak-sales-potential-in-kidney-diseases-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SKIS","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997327","title":"Jasper Therapeutics Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997327?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:32","pubTimestamp":1786527120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JSPR/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658592212","title":"Jasper Therapeutics, Inc. : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $2","url":"https://stock-news.laohu8.com/highlight/detail?id=2658592212","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658592212?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:41","pubTimestamp":1786520481,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657164293","title":"Jasper Therapeutics, Inc. Expected to Post a Loss of 35 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657164293","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657164293?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:01","pubTimestamp":1786114909,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. <JSPR.OQ> expected to post a loss of35cents a share - Earnings PreviewJasper Therapeutics, Inc.JSPR.OQJSPR.Ois expected to  show no change in quarterly revenue when it report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569766","title":"Jasper Therapeutics Halts Briquilimab Extension Study in Chronic Urticaria: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569766?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:30","pubTimestamp":1786033831,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. ($JSPR) announced an update on their ongoing clinical study. This Phase 2 extension study, titled “Open-Label Extension S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-halts-briquilimab-extension-study-in-chronic-urticaria-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-halts-briquilimab-extension-study-in-chronic-urticaria-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4139","JSPR","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656973","title":"JSPR Completes Briquilimab Trial In Chronic Hives, Setting Up Next Risk–Reward Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656973?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:30","pubTimestamp":1786033820,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. ($JSPR) announced an update on their ongoing clinical study. Jasper Therapeutics, Inc. (JSPR) has completed a Phase 1b/2a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jspr-completes-briquilimab-trial-in-chronic-hives-setting-up-next-risk-reward-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jspr-completes-briquilimab-trial-in-chronic-hives-setting-up-next-risk-reward-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656001563","title":"Jasper Therapeutics Shareholders Back Board, Auditors, Pay Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2656001563","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656001563?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:31","pubTimestamp":1785796268,"startTime":"0","endTime":"0","summary":"An update from Jasper Therapeutics ( ($JSPR) ) is now available. On July 31, 2026, Jasper Therapeutics, Inc. held its 2026 Annual Meeting of Stockh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-shareholders-back-board-auditors-pay-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-shareholders-back-board-auditors-pay-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656302940","title":"Jasper Therapeutics Holds Annual Stockholders Meeting; 75% of Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2656302940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656302940?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:55","pubTimestamp":1785790552,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics holds annual stockholders meeting; 75% of shares representedJasper Therapeutics held its annual shareholder meeting on July 31, 2026.Shareholders selected two Class II directors to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL84d9WC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653791200","title":"Jasper Therapeutics COO Matthew E. Ros Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653791200","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653791200?lang=en_us&edition=fundamental","pubTime":"2026-07-23 07:11","pubTimestamp":1784761873,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statementJasper Therapeutics COO Matthew E. Ros reported stock options for 103,204 voting common shares at USD 0.01.Disclaimer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL85PZwl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653244050","title":"Jasper Therapeutics Director Patrick J. Crutcher Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653244050","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653244050?lang=en_us&edition=fundamental","pubTime":"2026-07-21 08:38","pubTimestamp":1784594319,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics director Patrick J. Crutcher files initial beneficial ownership statementJasper Therapeutics director Patrick J. Crutcher reported 518,331 voting common shares in an initial Form 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL25W8f7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652440203","title":"Jasper Therapeutics Completes Kira Acquisition and PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652440203","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652440203?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:32","pubTimestamp":1784284320,"startTime":"0","endTime":"0","summary":"An announcement from Jasper Therapeutics ( ($JSPR) ) is now available. On July 16, 2026, Jasper Therapeutics completed an all-stock acquisition of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-completes-kira-acquisition-and-pipe-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-completes-kira-acquisition-and-pipe-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR","PIPE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":0.166},{"period":"3month","weight":-0.156},{"period":"6month","weight":-0.493},{"period":"1year","weight":-0.7536},{"period":"ytd","weight":-0.6177}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.285776},{"month":2,"riseRate":0.428571,"avgChangeRate":0.093912},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.063229},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.031704},{"month":5,"riseRate":0.714286,"avgChangeRate":0.025166},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.150942},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.014598},{"month":8,"riseRate":0.571429,"avgChangeRate":0.009389},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.2127},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.027786},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.069737},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008174}],"exchange":"NASDAQ","name":"Jasper Therapeutics","nameEN":"Jasper Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jasper Therapeutics,JSPR,Jasper Therapeutics股票,Jasper Therapeutics股票老虎,Jasper Therapeutics股票老虎国际,Jasper Therapeutics行情,Jasper Therapeutics股票行情,Jasper Therapeutics股价,Jasper Therapeutics股市,Jasper Therapeutics股票价格,Jasper Therapeutics股票交易,Jasper Therapeutics股票购买,Jasper Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}